Evidence map›Paper›PMID 22405692›Full record

ReviewBrain research2012

Targeting inhibitory neurotransmission in tinnitus.

Ben D Richardson, Thomas J Brozoski, Lynne L Ling, Donald M Caspary

Abstract readReview
In one paragraph

Review in Brain research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 90 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Current understanding of subjective tinnitus in adults.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ben D RichardsonDepartment of Pharmacology, Southern Illinois University School of Medicine, 801 N Rutledge St, Rm. 3234, PO Box 19629, Springfield, IL 62794, USA. brichardson@siumed.edu
Thomas J Brozoski
Lynne L Ling
Donald M Caspary
Southern Illinois University School of Medicine · US

Funding

CODING IN AUDITORY NEURONS: EFFECTS OF AMINO ACIDSR01DC000151 · NIDCD · SOUTHERN ILLINOIS UNIVERSITY SCH OF MED · PI CASPARY, DONALD M. · 1989 to 2024
$7.1M
Features of chronic tinnitus in an animal model as indicated by MEMRI and MRSR01DC009669 · NIDCD · SOUTHERN ILLINOIS UNIVERSITY SCH OF MED · PI BAUER, CAROL A., BROZOSKI, THOMAS J. · 2008 to 2012
$2.0M
The Glycine Receptor in a Rat Tinnitus Model: A Possible Therapeutic TargetR01DC008532 · NIDCD · SOUTHERN ILLINOIS UNIVERSITY SCH OF MED · PI CASPARY, DONALD M. · 2007 to 2011
$1.5M
NIDCD NIH HHS DC008532NIDCD NIH HHS DC009669NIDCD NIH HHS R01 DC000151NIDCD NIH HHS R01 DC008532NIDCD NIH HHS R01 DC009669
6 · The paper itself

Abstract

Tinnitus perception depends on the presence of its neural correlates within the auditory neuraxis and associated structures. Targeting specific circuits and receptors within the central nervous system in an effort to relieve the perception of tinnitus and its impact on one's emotional and mental state has become a focus of tinnitus research. One approach is to upregulate endogenous inhibitory neurotransmitter levels (e.g., glycine and GABA) and selectively target inhibitory receptors in key circuits to normalize tinnitus pathophysiology. Thus, the basic functional and molecular properties of two major ligand-gated inhibitory receptor systems, the GABA(A) receptor (GABA(A)R) and glycine receptor (GlyR) are described. Also reviewed is the rationale for targeting inhibition, which stems from reported tinnitus-related homeostatic plasticity of inhibitory neurotransmitter systems and associated enhanced neuronal excitability throughout most central auditory structures. However, the putative role of the medial geniculate body (MGB) in tinnitus has not been previously addressed, specifically in terms of its inhibitory afferents from inferior colliculus and thalamic reticular nucleus and its GABA(A)R functional heterogeneity. This heterogeneous population of GABA(A)Rs, which may be altered in tinnitus pathology, and its key anatomical position in the auditory CNS make the MGB a compelling structure for tinnitus research. Finally, some selective compounds, which enhance tonic inhibition, have successfully ameliorated tinnitus in animal studies, suggesting that the MGB and, to a lesser degree, the auditory cortex may be their primary locus of action. These pharmacological interventions are examined in terms of their mechanism of action and why these agents may be effective in tinnitus treatment. This article is part of a Special Issue entitled: Tinnitus Neuroscience.

Indexed as

HumansMicroscopy, ConfocalNeuronsNeurotransmitter AgentsRadioligand AssayReceptors, NeurotransmitterSynaptic TransmissionThalamusTinnitusNeurotransmitter AgentsReceptors, Neurotransmitter

Identifiers

PMID22405692
PMCPMC3374875
OpenAlexW2063913143

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.